These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 27401451)

  • 1. Combined delivery of temozolomide and the thymidine kinase gene for treatment of glioblastoma.
    Choi E; Han J; Tan X; Oh J; Lee D; Rhim T; Lee M
    J Drug Target; 2017 Feb; 25(2):156-162. PubMed ID: 27401451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thymidine kinase gene delivery using curcumin loaded peptide micelles as a combination therapy for glioblastoma.
    Park JH; Han J; Lee M
    Pharm Res; 2015 Feb; 32(2):528-37. PubMed ID: 25158647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peptide micelle-mediated delivery of tissue-specific suicide gene and combined therapy with avastin in a glioblastoma model.
    Oh B; Han J; Choi E; Tan X; Lee M
    J Pharm Sci; 2015 Apr; 104(4):1461-9. PubMed ID: 25631673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amphiphilic peptide carrier for the combined delivery of curcumin and plasmid DNA into the lungs.
    Park JH; Kim HA; Park JH; Lee M
    Biomaterials; 2012 Sep; 33(27):6542-50. PubMed ID: 22687757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A ternary-complex of a suicide gene, a RAGE-binding peptide, and polyethylenimine as a gene delivery system with anti-tumor and anti-angiogenic dual effects in glioblastoma.
    Choi E; Oh J; Lee D; Lee J; Tan X; Kim M; Kim G; Piao C; Lee M
    J Control Release; 2018 Jun; 279():40-52. PubMed ID: 29660374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temozolomide enhances herpes simplex virus thymidine kinase/ganciclovir therapy of malignant glioma.
    Rainov NG; Fels C; Droege JW; Schäfer C; Kramm CM; Chou TC
    Cancer Gene Ther; 2001 Sep; 8(9):662-8. PubMed ID: 11593335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-21 inhibition enhances in vitro chemosensitivity of temozolomide-resistant glioblastoma cells.
    Wong ST; Zhang XQ; Zhuang JT; Chan HL; Li CH; Leung GK
    Anticancer Res; 2012 Jul; 32(7):2835-41. PubMed ID: 22753745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liposomal temozolomide drug delivery using convection enhanced delivery.
    Nordling-David MM; Yaffe R; Guez D; Meirow H; Last D; Grad E; Salomon S; Sharabi S; Levi-Kalisman Y; Golomb G; Mardor Y
    J Control Release; 2017 Sep; 261():138-146. PubMed ID: 28666727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of an optimal dosing schedule for combining Irinophore C™ and temozolomide in an orthotopic model of glioblastoma.
    Verreault M; Wehbe M; Strutt D; Masin D; Anantha M; Walker D; Chu F; Backstrom I; Kalra J; Waterhouse D; Yapp DT; Bally MB
    J Control Release; 2015 Dec; 220(Pt A):348-357. PubMed ID: 26528901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. APE1/REF-1 down-regulation enhances the cytotoxic effects of temozolomide in a resistant glioblastoma cell line.
    Montaldi AP; Godoy PR; Sakamoto-Hojo ET
    Mutat Res Genet Toxicol Environ Mutagen; 2015 Nov; 793():19-29. PubMed ID: 26520369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MAPK8 mediates resistance to temozolomide and apoptosis of glioblastoma cells through MAPK signaling pathway.
    Xu P; Zhang G; Hou S; Sha LG
    Biomed Pharmacother; 2018 Oct; 106():1419-1427. PubMed ID: 30119215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temozolomide-loaded photopolymerizable PEG-DMA-based hydrogel for the treatment of glioblastoma.
    Fourniols T; Randolph LD; Staub A; Vanvarenberg K; Leprince JG; Préat V; des Rieux A; Danhier F
    J Control Release; 2015 Jul; 210():95-104. PubMed ID: 25982679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zinc enhances temozolomide cytotoxicity in glioblastoma multiforme model systems.
    Toren A; Pismenyuk T; Yalon M; Freedman S; Simon AJ; Fisher T; Moshe I; Reichardt JK; Constantini S; Mardor Y; Last D; Guez D; Daniels D; Assoulin M; Mehrian-Shai R
    Oncotarget; 2016 Nov; 7(46):74860-74871. PubMed ID: 27556862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of tumor treating fields and temozolomide in MGMT expressing and non-expressing patient-derived glioblastoma cells.
    Clark PA; Gaal JT; Strebe JK; Pasch CA; Deming DA; Kuo JS; Robins HI
    J Clin Neurosci; 2017 Feb; 36():120-124. PubMed ID: 27865821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Propolis changes the anticancer activity of temozolomide in U87MG human glioblastoma cell line.
    Markiewicz-Żukowska R; Borawska MH; Fiedorowicz A; Naliwajko SK; Sawicka D; Car H
    BMC Complement Altern Med; 2013 Feb; 13():50. PubMed ID: 23445763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Convection-enhanced delivery of a synthetic retinoid Am80, loaded into polymeric micelles, prolongs the survival of rats bearing intracranial glioblastoma xenografts.
    Yokosawa M; Sonoda Y; Sugiyama S; Saito R; Yamashita Y; Nishihara M; Satoh T; Kumabe T; Yokoyama M; Tominaga T
    Tohoku J Exp Med; 2010 Aug; 221(4):257-64. PubMed ID: 20622491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of GSH synthesis potentiates temozolomide-induced bystander effect in glioblastoma.
    Kohsaka S; Takahashi K; Wang L; Tanino M; Kimura T; Nishihara H; Tanaka S
    Cancer Lett; 2013 Apr; 331(1):68-75. PubMed ID: 23246370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delivery of a drug cache to glioma cells overexpressing platelet-derived growth factor receptor using lipid nanocarriers.
    Miller K; Dixit S; Bredlau AL; Moore A; McKinnon E; Broome AM
    Nanomedicine (Lond); 2016 Mar; 11(6):581-95. PubMed ID: 27003178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomimetic cell membrane-coated DNA nanoparticles for gene delivery to glioblastoma.
    Han S; Lee Y; Lee M
    J Control Release; 2021 Oct; 338():22-32. PubMed ID: 34391836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temozolomide Resistance in Glioblastoma Cell Lines: Implication of MGMT, MMR, P-Glycoprotein and CD133 Expression.
    Perazzoli G; Prados J; Ortiz R; Caba O; Cabeza L; Berdasco M; Gónzalez B; Melguizo C
    PLoS One; 2015; 10(10):e0140131. PubMed ID: 26447477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.